These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4248948)

  • 1. [The fungal flora of nails changed by disease in the district of Dresden and their sensitivity to pimaricin].
    Blaschke-Hellmessen R
    Mykosen; 1968 Jul; 11(7):491-502. PubMed ID: 4248948
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complex sensitivity to pimaricin of fungi and molds isolated from sputum].
    Tomásová E; Závadová M
    Cesk Epidemiol Mikrobiol Imunol; 1971 May; 20(3):148-52. PubMed ID: 4254910
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fungal flora of diseased and healthy toenails].
    Seebacher C
    Mykosen; 1968 Dec; 11(12):893-902. PubMed ID: 4249080
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of amphotericin-B pimaricin and gentian violet on ocular fungi.
    Lavingia B; Dave S
    Indian J Ophthalmol; 1986; 34():73-7. PubMed ID: 3155339
    [No Abstract]   [Full Text] [Related]  

  • 5. [Onychomycosis caused by non dermatophyte filamentous fungus].
    del Palacio A; Pazos C; Cuétara S
    Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):439-42. PubMed ID: 11709123
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
    Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mold infections of the toe nails].
    Schönborn C; Schmoranzer H
    Mykosen; 1970 May; 13(5):253-72. PubMed ID: 4248860
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fungostatic activity in vitro of the new antibiotic--pimaricin (natamycin)].
    Porebska A; Laskownicka Z; Zemburowa K
    Med Dosw Mikrobiol; 1971; 23(1):71-6. PubMed ID: 5314225
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of onychomycosis with oral antifungal agents.
    Iorizzo M; Piraccini BM; Rech G; Tosti A
    Expert Opin Drug Deliv; 2005 May; 2(3):435-40. PubMed ID: 16296765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increasing frequency of onychomycoses--is there a change in the spectrum of infectious agents?].
    Ginter G; Rieger E; Heigl K; Propst E
    Mycoses; 1996; 39 Suppl 1():118-22. PubMed ID: 8767283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro fungistatic and fungicidal activities of silver sulfadiazine and natamycin on pathogenic fungi isolated from horses with keratomycosis.
    Betbeze CM; Wu CC; Krohne SG; Stiles J
    Am J Vet Res; 2006 Oct; 67(10):1788-93. PubMed ID: 17014335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
    Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI
    Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.
    Torres-Rodríguez JM; Madrenys-Brunet N; Siddat M; López-Jodra O; Jimenez T
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):25-31. PubMed ID: 9731962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antifungal activity in vitro of Scutellaria baicalensis Georgi upon cutaneous and ungual pathogenic fungi].
    Yang D; Michel D; Bevalot F; Chaumont JP; Millet-Clerc J
    Ann Pharm Fr; 1995; 53(3):138-41. PubMed ID: 7677396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the new antifungal antibiotic mucidin. I. Semiquantitative comparison of the activities of mucidin, nystatin and pimaricin.
    Sasek V; Musílek V
    Folia Microbiol (Praha); 1974; 19(2):139-41. PubMed ID: 4548038
    [No Abstract]   [Full Text] [Related]  

  • 16. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.
    Ghannoum MA; Hajjeh RA; Scher R; Konnikov N; Gupta AK; Summerbell R; Sullivan S; Daniel R; Krusinski P; Fleckman P; Rich P; Odom R; Aly R; Pariser D; Zaiac M; Rebell G; Lesher J; Gerlach B; Ponce-De-Leon GF; Ghannoum A; Warner J; Isham N; Elewski B
    J Am Acad Dermatol; 2000 Oct; 43(4):641-8. PubMed ID: 11004620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
    Carrillo-Muñoz AJ; Quindós G; Del Valle O; Santos P; Giusiano G; Guardia C; Eraso E; Ezkurra PA; Tur-Tur C; Hernández-Molina JM
    J Chemother; 2008 Aug; 20(4):521-3. PubMed ID: 18676237
    [No Abstract]   [Full Text] [Related]  

  • 18. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice.
    Svejgaard EL; Nilsson J
    Mycoses; 2004 Apr; 47(3-4):131-5. PubMed ID: 15078429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of fungi isolated from onychomycosis to Eugenia cariophyllata essential oil and eugenol.
    Gayoso CW; Lima EO; Oliveira VT; Pereira FO; Souza EL; Lima IO; Navarro DF
    Fitoterapia; 2005 Mar; 76(2):247-9. PubMed ID: 15752642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China.
    Xie L; Zhai H; Zhao J; Sun S; Shi W; Dong X
    Am J Ophthalmol; 2008 Aug; 146(2):260-265. PubMed ID: 18547535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.